WO2005112821A2 - Enhanced biological fixation of grafts - Google Patents
Enhanced biological fixation of grafts Download PDFInfo
- Publication number
- WO2005112821A2 WO2005112821A2 PCT/US2005/017878 US2005017878W WO2005112821A2 WO 2005112821 A2 WO2005112821 A2 WO 2005112821A2 US 2005017878 W US2005017878 W US 2005017878W WO 2005112821 A2 WO2005112821 A2 WO 2005112821A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- graft
- tubular body
- stent graft
- stent
- biocompatible
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/848—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/89—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
- A61F2002/0086—Special surfaces of prostheses, e.g. for improving ingrowth for preferentially controlling or promoting the growth of specific types of cells or tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/848—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
- A61F2002/8486—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs provided on at least one of the ends
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
- A61F2220/0016—Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/005—Rosette-shaped, e.g. star-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0067—Three-dimensional shapes conical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0039—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
Definitions
- This invention relates to a graft material and more particularly to a graft material with enhanced or improved potential for biological fixation on or in the human or animal body.
- Background of the Invention This invention will be generally discussed in relation to its application to endoluminally deployed grafts and stent grafts but the invention is not so limited and can also be applied to the grafts to be applied to or in the human or animal body and where biological fixation is a desired or necessary function.
- Stent grafts for endoluminal deployment into body lumens of a human or animal are generally formed from a tube of a biocompatible material and a stent or stents to maintain a lumen therethrough.
- Such grafts are used to span a damaged portion of the lumen such as an abdominal aortic aneurysm.
- the stent graft engages against the wall of the lumen either side of the aneurysm in a region referred to as a landing zone. It is desirable to have some fixation to the wall of the lumen in the landing zone to ensure that the stent graft will not migrate.
- proximal fixation in the neck region of the aorta of an abdominal aortic aneurysm stent-graft is a critical function with respect to long term durability of endovascular repair. This is important because pulsating blood in the aorta can provide considerable forces on a stent graft.
- a third fixation force tissue encapsulation, occurs in some devices over a much longer time frame (up to many months or even years).
- Exposed stainless steel stent struts such as the renal stent in some forms of abdominal aortic aneurysm (AAA) stent-graft device, eventually become completely encapsulated (each strut is surrounded) by tissue growth resulting in additional and significant fixation.
- the interference fit and to some extent encapsulation mechanism provide sealing required to exclude the aneurysm which is the purpose of the device.
- vascular graft In the case of a vascular graft, cell ingrowth is important to avoid the formation of thrombus, create a seal, and to secure the graft intra or interluminally.
- the most thrombo-resistant material known is a monolayer of endothelial cells. Without cell ingrowth into a graft, it is has been virtually impossible to achieve a monolayer of endothelial cells using traditional graft materials. Also, without cellular ingrowth, fixation and sealing of the device is left to mechanical means, which could fail over time.
- ePTFE expanded poly tetrafluoethylene
- Tissue ingrowth has been sacrificed to ensure that type IV endoleaks (leakage due to high porosity graft material) are eliminated. Fixation and sealing are achieved through mechanical means as discussed above and thrombus is not seen as an eminent concern due to the high flow rate in large diameter grafts. It is an object of this invention provides a biological fixation mechanism which does not rely on these secondary mechanical anchoring forces or to at least provide a physician with an alternative fixation mechanism.
- distal with respect to a portion of the aorta, a deployment device or a prosthesis is the end of the aorta, deployment device or prosthesis further away in the direction of blood flow away from the heart and the term proximal means the portion of the aorta, deployment device or end of the prosthesis nearer to the heart.
- proximal means the portion of the aorta, deployment device or end of the prosthesis nearer to the heart.
- a stent graft comprising a substantially tubular body having a proximal end and a distal end, at least the proximal end comprising a region intended in use to engage a landing zone in a vessel in the body in use, the region comprising a mechanical treatment to enhance biological fixation to the landing zone.
- the mechanical treatment can be selected from the group comprising provision of apertures, provision of relatively rigid, as hereinafter described, engagement portions, impregnation with a SIS gel or digest and mounting of a SIS cuff or collar.
- the invention comprises a stent graft comprising a substantially tubular body having a proximal end and a distal end, at least the proximal end comprising a plurality of relatively rigid engagement portions extending radially outward therefrom to engage a landing zone in a vessel in the body in use.
- the plurality of relatively rigid engagement portions are placed on that portion of the stent graft which in use is expected to engage against the landing zone of the vessel as discussed above.
- the term relatively rigid is intended to mean that the engagement portions are made from a material which when engaged against the wall of a lumen into which the stent graft is deployed deforms the wall at the region of engagement of the engagement portion.
- the material of the engagement portions should be more rigid than the vessel walls.
- the engagement portions may be comprised of a metal, synthetic fiber or thread or a polymeric material.
- the engagement portions may be in the form of loops, coils, angled portions, buttons, spikes or other protrusions or the like.
- the engagement portions may be formed onto the tubular body by stitching, adhesion or threading a further material or extra portions of the same material of the graft into the material of the tubular body.
- the engagement portions are resilient so that they can be compressed into a introducer device for endoluminal deployment.
- the engagement portions provide a matrix of radially outward protruding portions when the stent graft is deployed and a stent associated with the graft is providing radially outward pressure.
- These protruding portions create a localized pressure (greater than 30 mmHg-to overcome capillary pressure) against the aorta wall initiating cell necrosis. After cell death the protruding portions will continue to impinge on the arterial wall leading to endothelial wall remodeling to accommodate the protruding portions.
- Each protruding portion may in time become completely encapsulated by tissue growth.
- the protruding portions introduced on the outside of the graft serve as scaffold for tissue (adventitia) to grow around each protruding portions creating a significant fixation and sealing mechanism.
- the process of mounting the engagement portions onto the tubular body may create "micro-dimensional" through-thickness holes or pores which will encourage cells to grow into and through the graft and achieve further biological fixation and sealing. ln a further form the invention is said to reside in a stent graft comprising a substantially tubular body of a biocompatible graft material, the tubular body having a proximal end and a distal end, the proximal end including an array of resilient wire loops extending radially outward from the tubular body.
- each wire loop is formed from a stainless steel or Nitinol wire.
- the each wire loop may be in the form of a semicircle, a coil, an angled portion or the like. At least some of the loops may be cut or otherwise severed to provide spike portions.
- the use of spikes to intentionally irritate the vessel wall is so that faster cell response may be expected. This may be critical for old patients, considering the fact that thrombosis/calcification may occur on the vessel wall and the cells in their vessels are not so aggressive as might be expected.
- the number and location of the spikes can be varied.
- the wire may have a diameter of from 3 to 10 microns and the loops formed on the tubular body may extend from the tubular body from 50 to 200 microns.
- the wire loops may be formed onto the tubular body by stitching, adhesion or threading into the weave of biocompatible material.
- the biocompatible graft material may be Dacron, expanded polytetrafluoroethylene (ePTFE), other synthetic biocompatible materials or a naturally occurring biomaterial, such as collagen.
- ePTFE expanded polytetrafluoroethylene
- a specially derived collagen material known as an extracellular matrix (ECM), such as small intestinal submucosa (SIS) is particularly preferred.
- ECM extracellular matrix
- examples of ECM's include pericardium, stomach submucosa, liver basement membrane, urinary bladder submucosa, tissue mucosa, and dura mater.
- a fixation mechanism that does not rely upon purely mechanical forces to prevent movement but is based on arterial tissue growth through the scaffolding created by the stitched loops or other types of engagement portion as well as direct tissue in- growth through the pores created by the stitching process.
- the invention is said to reside in a graft comprising a synthetic biocompatible graft material, at least a portion of the graft material having a biologically active material associated therewith.
- This biologically active material will promote tissue re-growth and remodeling at an accelerated pace.
- this invention supplements the current fixation techniques by providing an enhanced biological fixation and sealing mechanism. In effect tissue growth into the synthetic graft material is promoted by the presence of the biologically active material.
- this biological fixation enhancement can be localized to the proximal and distal neck regions where attachment is critical for fixation and sealing.
- the fixation and sealing of a graft incorporating the biological fixation enhancement of the present invention is biological and permanent and does not require a long term and less reliable mechanical fixation mechanism which are problematic at best.
- Various methods and designs can be used to associate the biologically active material with the synthetic graft material. Methods can include attaching, infusing, encapsulation, etc. the biologically active material to the graft material in ways that will survive the manufacturing process and be delivered to the neck region, for instance of a stent graft, intact until the tissue in-growth and biological fixation is complete.
- the graft may be in a form of a stent graft and the biologically active material can be associated with the graft material at at least a proximal region of the stent graft in a region which may be referred to as a landing zone for engagement with a vessel wall.
- the biologically active material can also be associated with the graft material at a distal region landing zone.
- the synthetic biocompatible material may be Dacron or expanded polytetrafluoroethylene.
- the biologically active material may be formed from a naturally occurring biomaterial, such as collagen, particularly a specially derived collagen material known as an extracellular matrix (ECM), such as small intestinal submucosa (SIS).
- ECM extracellular matrix
- SIS small intestinal submucosa
- ECM's include pericardium, stomach submucosa, liver basement membrane, urinary bladder submucosa, tissue mucosa, and dura mater.
- SIS is particularly useful, and can be made in the fashion described in Badylaketal., US Patent 4,902,508; Intestinal Collagen Layer described in US Patent 5,733,337 to Carr and in 17 Nature Biotechnology 1083 (Nov. 1999); Cook et al.,
- the natural porosity of a woven fabric (which can be altered by various weaving strategies) can allow the infusing into the graft of a SIS gel by applying a vacuum on one side of the graft and "pulling" the SIS gel into the interstices which form the natural porosity of the graft.
- a second method by which a biologically active material can be associated with the synthetic biocompatible graft material may be by vacuum press a SIS sheet onto the synthetic graft material with the use of a SIS gel as an adhesive.
- SIS sheet is a proven product capable of providing a collagen scaffolding enhanced with natural porcine growth factors and other proteins.
- SIS gel as a "glue" both connects the SIS sheet to the graft as well as promoting further tissue-graft in-growth.
- One possible manufacturing process is to apply the SIS gel and SIS sheet on to the outside of the graft and then "vacuum-pull" the graft so that SIS gel can penetrate the graft, subsequently polymerize the composite graft in the oven at 37 ° C for 20 minutes and then freeze dry and /or vacuum press the composite graft.
- a third method by which a biologically active material can be associated with the synthetic biocompatible graft material may be by attaching SIS sheet by use of metal or synthetic biocompatible fiber or thread.
- SIS sheet can be stitched on to a synthetic graft so as to form a secure and permanent mechanical attachment.
- SIS gel can then be used as a "binder" by following the steps described in the second method to fill the pores created by the stitching process and further, any protruding fibers can form a mechanical scaffolding to hold the SIS gel in place.
- the stitching can be done using a biocompatible thread such as a suture thread or by the use of a wire thread. At least some of the stitching with the biocompatible thread such as a suture thread or by the use of a wire thread can extend beyond the outer surface of the stent graft and provide a plurality of relatively rigid engagement portions extending radially outward therefrom to enhance fixation.
- the invention is said to reside in a graft comp ⁇ sing a biocompatible graft material, at least a portion of the graft material having a selected porosity to allow cell in-growth and still provide an adequate short term seal and fixation.
- the invention is said to reside in a stent graft comprising a tubular body of a biocompatible graft material defining a lumen therethrough and having a proximal end and a distal end, at least a portion along the length of the proximal end of the tubular body having a selected porosity to allow cell in-growth.
- the porosity may be provided by an array of apertures in the biocompatible graft material.
- the aperture may have a diameter in the range of from 20 microns to 120 microns and a spacing of from 20 to 250 microns.
- the apertures may be formed in the biocompatible graft material by the use of laser drilling. Lasers provide a small beam spot, accurate drilling depth control, and minimum heat affected area. Excimer lasers are specifically noted for theirdegree of precision and minimal damage to surrounding material. Lasers have the capability to drill holes smaller than 50 microns at varying interpore distances. In an alternative form the selected porosity may be provided by modification of the weave pattern of the biocompatible fibres which make up the graft material.
- a region at the proximal end of the stent graft may be woven in such a way as to provide apertures between the warp or weft fibres.
- Such aperture may have opening dimensions in the region of from 20 microns to 100 microns.
- the invention is said to reside in a method of producing a graft material adapted for biological fixation in the human or animal body comprising the step of ablating a plurality of apertures into the graft material, the apertures having a diameter in the range of from 20 microns to 120 microns and a spacing of from 20 to 250 microns.
- the ablation is done with a laser.
- the invention comprises a stent graft comprising a substantially tubular body of a biocompatible graft material, the tubular body having a proximal end and a distal end, at least the proximal end including a cuff or collar of SIS or some other biocompatible material to create a localized pressure on a landing zone in use thereby initiating cell necrosis and subsequent endothelial wall remodeling against the aorta wall to accommodate the protruding portions to enhance biological fixation of the stent graft to the landing zone.
- a stent graft that has enhanced biological fixation.
- Figure 1 shows a perspective view of a portion of a stent graft incorporating a biological fixation arrangement according to one embodiment of the present invention
- Figure 2 shows a cross sectional view of the stent graft along the line 2 - 2' in Figure 1
- Figure 3 shows a perspective view of a portion of a stent graft incorporating the biological fixation arrangements according to an alternative embodiment of the present invention
- Figure 4 shows a cross sectional view of the stent graft along the line 4 - 4' in Figure 3
- Figures 5a to 5d show details of various shapes of engagement portions according to an embodiment the present invention
- Figure 6 shows a perspective view of a portion of a stent graft incorporating an alternative embodiment of a biological fixation arrangement according to the present invention
- Figure 7 shows an enlarged view of a portion of the graft material of Figure 6 showing a method by which SIS can be associated with the graft material
- Figure 8 shows an enlarged view of a portion of a graf
- FIG. 11 showing how SIS can be impregnated into the graft material
- Figure 13 shows an enlarged view of a portion of the resulting graft material of Figure 12
- Figure 14 shows a perspective view of a portion of a stent graft incorporating an alternative embodiment of a biological fixation arrangement according to the present invention
- Figure 15 shows an enlarged view of a portion of the graft material shown in Figure 14.
- Figure 1 shows a perspective view of a portion of a stent graft incorporating biological fixation arrangements according to one embodiment of the present invention.
- the stent graft 1 has a tubular body 3 of a biocompatible material such as a woven Dacron.
- This proximally extending Z stent 7 has barbs 9 extending from struts 11 of the stent 7.
- the barbs 9 engage into the wall of the aorta and provide a purely mechanical immediate fixation of the stent graft into the vessel.
- An added long term biological fixation is therefore provided according to this invention.
- the added long term biological fixation is provided by a plurality of engagement portions 17 which are fastened to the tubular body towards the proximal end 5 thereof and which extend radially outwards from the tubular body.
- the plurality of engagement portions 17 are provided by loops of stiff polymer thread, stainless steel or Nitinol wire.
- the stiff polymer thread can for instance be a suture thread.
- the loops can be stitched to the tubular body by using a sewing machine or other similar machine. During the sewing process, the small loops 17 can be created on the outside of the tubular body of the stent graft
- Figure 2 shows a cross sectional view of the stent graft along the line 2 - 2' in Figure 1.
- the tubular body 3 of the stent graft 1 has the wire loops 17 stitched into it with an internal thread 19 catching the ends of each loop.
- a semicircular shape is shown in Figure 2, the loops can be stitched in many shapes, and multiple bands of loops can be stitched to the areas where the maximal fixation is desired.
- the loops do not necessarily have to be circular in shape, rather can take sharper forms such as an ellipse or right angled.
- FIG 3 shows a perspective view of a portion of a stent graft incorporating the biological fixation arrangements according to an alternative embodiment of the present invention.
- the stent graft 1 has a tubular body 3 of a biocompatible material such as a woven Dacron.
- the tubular body 3 there are self expanding Z stents 13 outside the tubular body and stitched to the tubular body.
- this proximal Z stent 15 provides pressure against the wall of the aorta in the landing zone and with the Z stent 15 within the tubular body an essentially smooth outer surface is presented to the wall of the aorta to provide a degree of initial sealing.
- proximal end 5 of the stent graft 1 there is also a proximally extending uncovered self expanding Z stent 7.
- This proximally extending Z stent 7 has barbs 9 extending from struts 11 of the stent 7.
- the added long term biological fixation of this embodiment is provided by a plurality of engagement portions 20 which are fastened to the tubular body towards the proximal end 5 thereof in that portion which is intended to engage with the landing zone when deployed as discussed above and which extend radially outwards from the tubular body.
- the plurality of engagement portions 20 are provided by loops of stiff polymer thread, stainless steel or Nitinol wire.
- the stiff polymer thread can for instance be a suture thread.
- the loops can be stitched to the tubular body by using a sewing machine or other similar machine. During the sewing process, the small metal wire loops 20 can be created on the outside of the tubular body of the stent graft 1. There can be several rows of loops as shown in Figure 3. At least some of the loops 20 are cut or otherwise severed at an apex of the loop to provide a pair of spikes 22 to engage against the wall of a vessel when deployed to intentionally irritate the vessel wall is so that faster cell response may be expected.
- FIG. 4 shows a cross sectional view of the stent graft along the line 4 - 4' in Figure 3.
- the tubular body 3 of the stent graft 1 has the wire loops 20 stitched into it with an internal wire 19 catching the ends of each loop.
- At least some of the loops are cut or otherwise formed into a spike or spikes at an apex of the loop to provide a pair of spikes 22 to engage against the wall of a vessel when deployed.
- a semicircular shape for the loops is shown in Figure 4, the metal wire can be stitched in many shapes, and multiple rings of wire can be stitched to the areas where the maximal fixation is desired.
- the wire "loops" do not necessarily have to be circular in shape, rather can take sharper forms such as an ellipse or right angled.
- Figures 5a to 5d show details of various shapes of engagement portions according to the present invention. In each case the engagement portions extend from the tubular body 30 of the stent graft.
- the engagement portions 32 are formed from a wire 34 which is stitched through the tubular body 30 in a series of semicircles.
- the engagement portions 36 are formed from a wire 38 which is stitched through the tubular body 30 in a series of angled portions.
- the engagement portions 40 are formed from a wire 42 which is stitched through the tubular body 30 in a series of coils or helices.
- the engagement portions 46 are individually formed from wires 48 which are formed into button shapes and mounted into the tubular body 30 and stitched through the tubular body 30 by stitches 50.
- the material from which the engagement portions are made is selected so that it is more rigid than the vessel wall of the vessel into which it is placed so that it deforms the wall, causes necrosis and tissue growth around the engagement portions.
- a material such as Nitinol in the form of a wire may provide an advantage due to its high degree of elastic (recoverable) strain.
- Other materials such as plastics materials, relatively stiff suture threads such as monofilament suture thread can also be used.
- the materials should also be resilient so that they can be compressed during deployment and upon release they can extend out to engage the wall of the aorta or other vessel.
- the engagement protrusions may have nano-scale surface features which may enhance tissue adhesion and spreading onto the surface of the engagement protrusions.
- FIG. 6 shows a perspective view of a portion of a stent graft incorporating the biological fixation arrangements according to an alternative embodiment of the present invention.
- the stent graft 1 has a tubular body 3 of a biocompatible material such as a woven Dacron.
- the tubular body 2 there are self expanding Z stents 13 outside the tubular body stitched to the tubular body.
- At the proximal end 5 there is an internal self expanding Z stent 15 again stitched to the body.
- this proximal Z stent 15 provides pressure against the wall of the aorta in the landing zone and as the Z stent 15 within the tubular body an essentially smooth outer surface is presented to the wall of the aorta to provide a degree of sealing.
- Atthe proximal end 5 of the stent graft 1 there is also a proximally extending uncovered self expanding Z stent 7.
- This proximally extending Z stent 7 has barbs 9 extending from struts 11 of the stent 7.
- the barbs 9 engage into the wall of the aorta and provide a purely mechanical immediate fixation of the stent graft into the vessel.
- migration caused by pulsating blood flow for instance, which may cause the barbs to tear the wall of the aorta.
- An added long term biological fixation is therefore provided according to this invention.
- the stent graft 1 includes a sheet of SIS material 60 in the form of a cuff or collar stitched onto the proximal end region 5 of the stent graft 1, in that portion which is intended to engage with the landing zone when deployed as discussed above, by means of wire stitches 62.
- the wire stitches 62 retain the SIS sheet material and have the added advantage that they provide apertures through the SIS and graft material which will permit cell growth through the material for enhanced biological fixation. At least some 64 of the wire stitches 62 extend our from the surface of the
- SIS sheet 60 and provide a matrix of radially outward protruding portions when the stent graft is deployed and a stent associated with the graft is providing radially outward pressure.
- These protruding portions may create a localised pressure (greater than 30 mmHg-to overcome capillary pressure) against the aorta wall initiating cell necrosis. After cell death the protruding portions will continue to impinge on the arterial wall leading to endothelial wall remodelling to accommodate the protruding portions. Each protruding portion may in time become completely encapsulated by tissue growth.
- FIG. 7 shows detail of the fastening of the sheet of SIS shown on Figure 6.
- a SIS gel is used as a binder.
- a SIS sheet is attached to a graft material by use of metal or synthetic biocompatible fibers or threads.
- SIS sheet can be stitched on to a synthetic graft so as to form a secure and permanent mechanical attachment. This technique can be enhanced by using a matrix of protruding stitches.
- a SIS gel can then be used as a "binder" by following the steps described in the embodiment shown in Figures 8 to 10 to fill the pores created by the stitching process and further, the protruding fibers can form a mechanical scaffolding to hold the SIS gel in place.
- the resulting SIS stitched composite structure will encourage cell growth through the fiber loops employing all the benefits of attachment and fixation described above.
- the graft material 3 in the region 61 has a cuff or collar formed from a sheet of SIS 60 attached to it by stitching using stitches 62 which extend through both the SIS 60 and graft material 3 to a back stitch 66.
- An intermediate layer 68 of a SIS gel or digest can provide both a "glue" to connect the SIS sheet to the graft as well as promote further tissue-graft in-growth.
- the stitches can be formed from stainless steel wire, Nitinol wire or suture material. Some of the loops 64 of the stitches 62 extend beyond the SIS to assist with biological fixation by engaging the wall of a vessel into which they are deployed and encouraging tissue growth around the loops.
- Figures 8 to 10 show a further embodiment of the invention to provide enhanced biological fixation. In this embodiment a sheet of SIS 70 is laid over the graft material 3 in a selected region of the stent graft with an intermediate layer 72 of a SIS gel or digest.
- a vacuum 73 is applied by means of a vacuum hood 74 and the gel or digest 72 drawn into the graft material 3 to give the result shown in Figure 9 where the sheet of SIS 70 is adhered to the graft material 3 using the SIS gel 72 as an adhesive.
- the composite is then polymerized by heating in an oven at 37C for 20 minutes and the resultant product is freeze dried or vacuum pressed to provide a product as shown on Figure 10.
- SIS sheet is a proven product capable of providing a collagen scaffolding enhanced with natural porcine growth factors and other proteins. This manufacturing technique utilizes the SIS sheet and attaches the sheet to the graft material in a secure fashion.
- the SIS gel is used as both a "glue" to connect the
- FIG 11 shows a perspective view of a portion of a stent graft incorporating the biological fixation arrangements according to a further embodiment of the present invention.
- the stent graft 1 has a tubular body 3 of a biocompatible material such as a woven Dacron.
- the tubular body 2 there are self expanding Z stents 13 outside the tubular body stitched to the tubular body.
- this proximal Z stent 15 provides pressure against the wall of the aorta in the landing zone and as the Z stent 15 within the tubular body an essentially smooth outer surface is presented to the wall of the aorta to provide a degree of sealing.
- proximal end 5 of the stent graft 1 there is also a proximally extending uncovered self expanding Z stent 7.
- This proximally extending Z stent 7 has barbs 9 extending from struts 11 of the stent 7.
- the barbs 9 engage into the wall of the aorta and provide a purely mechanical immediate fixation of the stent graft into the vessel.
- migration caused by pulsating blood flow for instance, which may cause the barbs to tear the wall of the aorta.
- An added long term biological fixation is therefore provided according to this invention.
- FIG. 12 In the portion of the stent graft 1 just distal of the proximal end 5 there is a region 80 around the circumference of the stent graft which is intended to engage against the landing zone in use and which has a SIS gel or a digest of SIS impregnated through the graft material tube 3.
- Figures 12 and 13 show this process in detail.
- a gel or digest of SIS 82 is applied to one surface of the graft material 3 in the region 80 and then a vacuum is applied by means of a vacuum hood 83 and the SIS gel or digest 82 is drawn into the graft material 3 to give the result shown in Figure 13.
- the natural porosity of the graft material can be altered by various weaving techniques to improve the amount of infusing into the graft of the SIS or by providing additional porosity in selected regions of the stent graft by drilling or ablating holes in the graft material using a laser or similar device. Such porosity may provide openings in the material of from 20 to 100 microns.
- the cell wall tissue can then grow into the graft material via the scaffolding provided by the SIS. Fixation occurs as the synthetic fiber/fiber-bundles are surrounded by new tissue growth, such as the collagen based adventitia which forms a bio-mechanical attachment mechanism (between the graft and artery wall). Sealing will also be a by-product of the tissue growth through the SIS filled graft.
- the endothelial cells will grow into the SIS on the inside of the graft wall forming a very smooth surface resulting in a non-thrombogenic graft property. Further, the resulting tissue in-growth will be biological active
- FIG 14 shows a perspective view of a portion of a stent graft incorporating the biological fixation arrangements according to an alternative embodiment of the present invention.
- the stent graft 1 has a tubular body 3 of a biocompatible material such as a woven Dacron.
- the stent graft 1 has a tubular body 3 of a biocompatible material such as a woven Dacron.
- the tubular body 2 there are self expanding Z stents 13 outside the tubular body stitched to the tubular body.
- this proximal Z stent 15 provides pressure against the wall of the aorta in the landing zone and with the Z stent 15 within the tubular body an essentially smooth outer surface is presented to the wall of the aorta to provide a degree of sealing.
- proximal end 5 of the stent graft 1 there is also a proximally extending uncovered self expanding Z stent 7.
- This proximally extending Z stent 7 has barbs 9 extending from struts 11 of the stent 7.
- the barbs 9 engage into the wall of the aorta and provide a purely mechanical immediate fixation of the stent graft into the vessel.
- An added long term biological fixation is therefore provided according to this invention.
- a region 90 around the circumference of the stent graft which has a selected porosity produced by a plurality of apertures 92 through the graft material tube 3.
- FIG. 15 shows an enlarged view of a portion of the graft material 3 of the stent graft 1.
- the material 3 in the region 90 has a plurality of apertures 92 ablated or drilled into it to provide the selected porosity.
- the apertures have a diameter of 50 microns and a spacing of 120 microns.
- the apertures may have a diameter in the range of from 20 microns to 120 microns and a spacing of from 20 to 250 microns.
- the apertures can be produced by the ablation of graft material via a photochemical laser drilling process.
- this laser is to break chemical bonds layer-by-layer, thus vaporizing the polymer with minimal heating. Thus minimal damage is done to the surrounding graft material.
- the nature of this laser is to break chemical bonds layer-by-layer, thus vaporizing the polymer with minimal heating. It is preferable to use some localized heating during the ablation process to provide a degree of fusing of fibre ends to enable the graft material to retain desired mechanical properties.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002567296A CA2567296A1 (en) | 2004-05-20 | 2005-05-20 | Enhanced biological fixation of grafts |
JP2007527502A JP2007537842A (en) | 2004-05-20 | 2005-05-20 | Enhanced biological fixation of grafts |
AU2005244993A AU2005244993B2 (en) | 2004-05-20 | 2005-05-20 | Enhanced biological fixation of grafts |
EP05757101A EP1750616A2 (en) | 2004-05-20 | 2005-05-20 | Enhanced biological fixation of grafts |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57280604P | 2004-05-20 | 2004-05-20 | |
US57280804P | 2004-05-20 | 2004-05-20 | |
US57280704P | 2004-05-20 | 2004-05-20 | |
US60/572,806 | 2004-05-20 | ||
US60/572,807 | 2004-05-20 | ||
US60/572,808 | 2004-05-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005112821A2 true WO2005112821A2 (en) | 2005-12-01 |
WO2005112821A3 WO2005112821A3 (en) | 2006-04-27 |
Family
ID=34971854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/017878 WO2005112821A2 (en) | 2004-05-20 | 2005-05-20 | Enhanced biological fixation of grafts |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1750616A2 (en) |
JP (1) | JP2007537842A (en) |
AU (1) | AU2005244993B2 (en) |
CA (1) | CA2567296A1 (en) |
WO (1) | WO2005112821A2 (en) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007098234A2 (en) * | 2006-02-21 | 2007-08-30 | Med Institute, Inc. | Graft material for prostheses |
JP2009525139A (en) * | 2006-02-03 | 2009-07-09 | ボルトン メディカル,インク. | Delivery system and method for automatically centering the proximal end of a stent graft |
JP2010538741A (en) * | 2007-09-13 | 2010-12-16 | ゴア エンタープライズ ホールディングス,インコーポレイティド | Vascular graft with stent |
EP2347731A1 (en) | 2004-05-20 | 2011-07-27 | Med Institute, Inc. | Enhanced biological fixation of grafts |
US8292943B2 (en) | 2003-09-03 | 2012-10-23 | Bolton Medical, Inc. | Stent graft with longitudinal support member |
US8449595B2 (en) | 2003-09-03 | 2013-05-28 | Bolton Medical, Inc. | Delivery systems for delivering and deploying stent grafts |
US8500792B2 (en) | 2003-09-03 | 2013-08-06 | Bolton Medical, Inc. | Dual capture device for stent graft delivery system and method for capturing a stent graft |
EP2769699A1 (en) * | 2013-02-20 | 2014-08-27 | Cook Medical Technologies LLC | Attachment of stent to graft fabric with an anchoring machine stitching |
US8998970B2 (en) | 2012-04-12 | 2015-04-07 | Bolton Medical, Inc. | Vascular prosthetic delivery device and method of use |
US9101506B2 (en) | 2009-03-13 | 2015-08-11 | Bolton Medical, Inc. | System and method for deploying an endoluminal prosthesis at a surgical site |
US9173755B2 (en) | 2003-09-03 | 2015-11-03 | Bolton Medical, Inc. | Vascular repair devices |
US9238090B1 (en) | 2014-12-24 | 2016-01-19 | Fettech, Llc | Tissue-based compositions |
WO2016054536A1 (en) * | 2014-10-02 | 2016-04-07 | Boston Scientific Scimed, Inc. | Controlled ingrowth feature for antimigration |
US9364314B2 (en) | 2008-06-30 | 2016-06-14 | Bolton Medical, Inc. | Abdominal aortic aneurysms: systems and methods of use |
US9439751B2 (en) | 2013-03-15 | 2016-09-13 | Bolton Medical, Inc. | Hemostasis valve and delivery systems |
US9877857B2 (en) | 2003-09-03 | 2018-01-30 | Bolton Medical, Inc. | Sheath capture device for stent graft delivery system and method for operating same |
US10765539B2 (en) | 2015-05-27 | 2020-09-08 | W. L. Gore & Associates, Inc. | Stent graft device with anchoring members having adjustable geometries |
US11259945B2 (en) | 2003-09-03 | 2022-03-01 | Bolton Medical, Inc. | Dual capture device for stent graft delivery system and method for capturing a stent graft |
US11523918B2 (en) * | 2011-12-06 | 2022-12-13 | Aortic Innovations, Llc | Transcatheter valve repair having improved paravalvular seal |
US11596537B2 (en) | 2003-09-03 | 2023-03-07 | Bolton Medical, Inc. | Delivery system and method for self-centering a proximal end of a stent graft |
US11759341B2 (en) | 2020-01-13 | 2023-09-19 | Boston Scientific Scimed, Inc. | Anti-migration stent |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3010828A1 (en) * | 2008-01-17 | 2009-07-23 | Boston Scientific Scimed, Inc. | Stent with anti-migration feature |
US8394138B2 (en) * | 2008-09-05 | 2013-03-12 | Cook Medical Technologies Llc | Multi-strand helical stent |
EP3160525B1 (en) | 2014-06-27 | 2023-08-09 | Boston Scientific Scimed, Inc. | Compositions, devices, kits and methods for attaching stent-containing medical devices to tissue |
WO2022009923A1 (en) * | 2020-07-07 | 2022-01-13 | 国立大学法人広島大学 | Stent graft |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000045737A1 (en) * | 1999-02-05 | 2000-08-10 | Pietro Quaretti | Urethral, biliary or esophagal tubular endoprosthesis |
US20020052649A1 (en) * | 2000-10-31 | 2002-05-02 | Greenhalgh E. Skott | Graft having region for biological seal formation |
US20020066360A1 (en) * | 2000-10-31 | 2002-06-06 | Greenhalgh E. Skott | Supported lattice for cell cultivation |
US20020123790A1 (en) * | 1999-09-28 | 2002-09-05 | White Geoffrey Hamilton | Enhanced engagement member for anchoring prosthetic devices in body lumen |
US20030120332A1 (en) * | 2001-12-19 | 2003-06-26 | Cook Incorporated | Stent graft with improved graft adhesion |
US20030204249A1 (en) * | 2002-04-25 | 2003-10-30 | Michel Letort | Endovascular stent graft and fixation cuff |
WO2005065583A1 (en) * | 2003-12-30 | 2005-07-21 | Scimed Life Systems, Inc | Non-porous graft with fastening elements |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2403276C (en) * | 2000-05-04 | 2009-10-20 | Oregon Health Sciences University | Endovascular stent graft |
-
2005
- 2005-05-20 JP JP2007527502A patent/JP2007537842A/en active Pending
- 2005-05-20 WO PCT/US2005/017878 patent/WO2005112821A2/en active Application Filing
- 2005-05-20 AU AU2005244993A patent/AU2005244993B2/en not_active Ceased
- 2005-05-20 CA CA002567296A patent/CA2567296A1/en not_active Abandoned
- 2005-05-20 EP EP05757101A patent/EP1750616A2/en not_active Withdrawn
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000045737A1 (en) * | 1999-02-05 | 2000-08-10 | Pietro Quaretti | Urethral, biliary or esophagal tubular endoprosthesis |
US20020123790A1 (en) * | 1999-09-28 | 2002-09-05 | White Geoffrey Hamilton | Enhanced engagement member for anchoring prosthetic devices in body lumen |
US20020052649A1 (en) * | 2000-10-31 | 2002-05-02 | Greenhalgh E. Skott | Graft having region for biological seal formation |
US20020066360A1 (en) * | 2000-10-31 | 2002-06-06 | Greenhalgh E. Skott | Supported lattice for cell cultivation |
US20030120332A1 (en) * | 2001-12-19 | 2003-06-26 | Cook Incorporated | Stent graft with improved graft adhesion |
US20030204249A1 (en) * | 2002-04-25 | 2003-10-30 | Michel Letort | Endovascular stent graft and fixation cuff |
WO2005065583A1 (en) * | 2003-12-30 | 2005-07-21 | Scimed Life Systems, Inc | Non-porous graft with fastening elements |
Cited By (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9907686B2 (en) | 2003-09-03 | 2018-03-06 | Bolton Medical, Inc. | System for implanting a prosthesis |
US8636788B2 (en) | 2003-09-03 | 2014-01-28 | Bolton Medical, Inc. | Methods of implanting a prosthesis |
US9877857B2 (en) | 2003-09-03 | 2018-01-30 | Bolton Medical, Inc. | Sheath capture device for stent graft delivery system and method for operating same |
US11596537B2 (en) | 2003-09-03 | 2023-03-07 | Bolton Medical, Inc. | Delivery system and method for self-centering a proximal end of a stent graft |
US11413173B2 (en) | 2003-09-03 | 2022-08-16 | Bolton Medical, Inc. | Stent graft with a longitudinal support member |
US11259945B2 (en) | 2003-09-03 | 2022-03-01 | Bolton Medical, Inc. | Dual capture device for stent graft delivery system and method for capturing a stent graft |
US8292943B2 (en) | 2003-09-03 | 2012-10-23 | Bolton Medical, Inc. | Stent graft with longitudinal support member |
US8308790B2 (en) | 2003-09-03 | 2012-11-13 | Bolton Medical, Inc. | Two-part expanding stent graft delivery system |
US8449595B2 (en) | 2003-09-03 | 2013-05-28 | Bolton Medical, Inc. | Delivery systems for delivering and deploying stent grafts |
US8500792B2 (en) | 2003-09-03 | 2013-08-06 | Bolton Medical, Inc. | Dual capture device for stent graft delivery system and method for capturing a stent graft |
US11103341B2 (en) | 2003-09-03 | 2021-08-31 | Bolton Medical, Inc. | Stent graft delivery device |
US8740963B2 (en) | 2003-09-03 | 2014-06-03 | Bolton Medical, Inc. | Methods of implanting a prosthesis and treating an aneurysm |
US10945827B2 (en) | 2003-09-03 | 2021-03-16 | Bolton Medical, Inc. | Vascular repair devices |
US10918509B2 (en) | 2003-09-03 | 2021-02-16 | Bolton Medical, Inc. | Aligning device for stent graft delivery system |
US10646365B2 (en) | 2003-09-03 | 2020-05-12 | Bolton Medical, Inc. | Delivery system and method for self-centering a proximal end of a stent graft |
US9173755B2 (en) | 2003-09-03 | 2015-11-03 | Bolton Medical, Inc. | Vascular repair devices |
US9198786B2 (en) | 2003-09-03 | 2015-12-01 | Bolton Medical, Inc. | Lumen repair device with capture structure |
US9220617B2 (en) | 2003-09-03 | 2015-12-29 | Bolton Medical, Inc. | Dual capture device for stent graft delivery system and method for capturing a stent graft |
US10390929B2 (en) | 2003-09-03 | 2019-08-27 | Bolton Medical, Inc. | Methods of self-aligning stent grafts |
US10213291B2 (en) | 2003-09-03 | 2019-02-26 | Bolto Medical, Inc. | Vascular repair devices |
US9320631B2 (en) | 2003-09-03 | 2016-04-26 | Bolton Medical, Inc. | Aligning device for stent graft delivery system |
US9333104B2 (en) | 2003-09-03 | 2016-05-10 | Bolton Medical, Inc. | Delivery systems for delivering and deploying stent grafts |
US10182930B2 (en) | 2003-09-03 | 2019-01-22 | Bolton Medical, Inc. | Aligning device for stent graft delivery system |
US9408735B2 (en) | 2003-09-03 | 2016-08-09 | Bolton Medical, Inc. | Methods of implanting a prosthesis and treating an aneurysm |
US9408734B2 (en) | 2003-09-03 | 2016-08-09 | Bolton Medical, Inc. | Methods of implanting a prosthesis |
US10105250B2 (en) | 2003-09-03 | 2018-10-23 | Bolton Medical, Inc. | Dual capture device for stent graft delivery system and method for capturing a stent graft |
US9925080B2 (en) | 2003-09-03 | 2018-03-27 | Bolton Medical, Inc. | Methods of implanting a prosthesis |
US9561124B2 (en) | 2003-09-03 | 2017-02-07 | Bolton Medical, Inc. | Methods of self-aligning stent grafts |
US9655712B2 (en) | 2003-09-03 | 2017-05-23 | Bolton Medical, Inc. | Vascular repair devices |
US9913743B2 (en) | 2003-09-03 | 2018-03-13 | Bolton Medical, Inc. | Methods of implanting a prosthesis and treating an aneurysm |
US11813158B2 (en) | 2003-09-03 | 2023-11-14 | Bolton Medical, Inc. | Stent graft delivery device |
EP2347731A1 (en) | 2004-05-20 | 2011-07-27 | Med Institute, Inc. | Enhanced biological fixation of grafts |
JP2009525139A (en) * | 2006-02-03 | 2009-07-09 | ボルトン メディカル,インク. | Delivery system and method for automatically centering the proximal end of a stent graft |
WO2007098234A2 (en) * | 2006-02-21 | 2007-08-30 | Med Institute, Inc. | Graft material for prostheses |
WO2007098234A3 (en) * | 2006-02-21 | 2008-08-21 | Med Inst Inc | Graft material for prostheses |
US8211168B2 (en) | 2006-02-21 | 2012-07-03 | Cook Biotech Incorporated | Graft material, stent graft and method |
JP2010538741A (en) * | 2007-09-13 | 2010-12-16 | ゴア エンタープライズ ホールディングス,インコーポレイティド | Vascular graft with stent |
US9364314B2 (en) | 2008-06-30 | 2016-06-14 | Bolton Medical, Inc. | Abdominal aortic aneurysms: systems and methods of use |
US10864097B2 (en) | 2008-06-30 | 2020-12-15 | Bolton Medical, Inc. | Abdominal aortic aneurysms: systems and methods of use |
US10307275B2 (en) | 2008-06-30 | 2019-06-04 | Bolton Medical, Inc. | Abdominal aortic aneurysms: systems and methods of use |
US11382779B2 (en) | 2008-06-30 | 2022-07-12 | Bolton Medical, Inc. | Abdominal aortic aneurysms: systems and methods of use |
US10105248B2 (en) | 2008-06-30 | 2018-10-23 | Bolton Medical, Inc. | Abdominal aortic aneurysms: systems and methods of use |
US10898357B2 (en) | 2009-03-13 | 2021-01-26 | Bolton Medical, Inc. | System for deploying an endoluminal prosthesis at a surgical site |
US9827123B2 (en) | 2009-03-13 | 2017-11-28 | Bolton Medical, Inc. | System for deploying an endoluminal prosthesis at a surgical site |
US9101506B2 (en) | 2009-03-13 | 2015-08-11 | Bolton Medical, Inc. | System and method for deploying an endoluminal prosthesis at a surgical site |
US11523918B2 (en) * | 2011-12-06 | 2022-12-13 | Aortic Innovations, Llc | Transcatheter valve repair having improved paravalvular seal |
US8998970B2 (en) | 2012-04-12 | 2015-04-07 | Bolton Medical, Inc. | Vascular prosthetic delivery device and method of use |
US10299951B2 (en) | 2012-04-12 | 2019-05-28 | Bolton Medical, Inc. | Vascular prosthetic delivery device and method of use |
US11351049B2 (en) | 2012-04-12 | 2022-06-07 | Bolton Medical, Inc. | Vascular prosthetic delivery device and method of use |
US9554929B2 (en) | 2012-04-12 | 2017-01-31 | Bolton Medical, Inc. | Vascular prosthetic delivery device and method of use |
US9700400B2 (en) | 2013-02-20 | 2017-07-11 | Cook Medical Technology LLC | Attachment of stent to graft fabric with an anchoring machine stitching |
EP2769699A1 (en) * | 2013-02-20 | 2014-08-27 | Cook Medical Technologies LLC | Attachment of stent to graft fabric with an anchoring machine stitching |
US11666467B2 (en) | 2013-03-15 | 2023-06-06 | Bolton Medical, Inc. | Hemostasis valve and delivery systems |
US10555826B2 (en) | 2013-03-15 | 2020-02-11 | Bolton Medical, Inc. | Hemostasis valve and delivery systems |
US9439751B2 (en) | 2013-03-15 | 2016-09-13 | Bolton Medical, Inc. | Hemostasis valve and delivery systems |
US10219921B2 (en) | 2014-10-02 | 2019-03-05 | Boston Scientific Scimed, Inc. | Controlled ingrowth feature for antimigration |
WO2016054536A1 (en) * | 2014-10-02 | 2016-04-07 | Boston Scientific Scimed, Inc. | Controlled ingrowth feature for antimigration |
US11590008B2 (en) | 2014-10-02 | 2023-02-28 | Boston Scientific Scimed, Inc. | Controlled ingrowth feature for antimigration |
US9238090B1 (en) | 2014-12-24 | 2016-01-19 | Fettech, Llc | Tissue-based compositions |
US11938246B2 (en) | 2014-12-24 | 2024-03-26 | Fettech, Llc | Tissue-based compositions and methods of use thereof |
CN112022459A (en) * | 2015-05-27 | 2020-12-04 | W.L.戈尔及同仁股份有限公司 | Stent graft device with anchor member having adjustable geometry |
US10765539B2 (en) | 2015-05-27 | 2020-09-08 | W. L. Gore & Associates, Inc. | Stent graft device with anchoring members having adjustable geometries |
US11944556B2 (en) | 2015-05-27 | 2024-04-02 | W. L. Gore & Associates, Inc. | Stent graft device with anchoring members having adjustable geometries |
US11759341B2 (en) | 2020-01-13 | 2023-09-19 | Boston Scientific Scimed, Inc. | Anti-migration stent |
Also Published As
Publication number | Publication date |
---|---|
AU2005244993A1 (en) | 2005-12-01 |
CA2567296A1 (en) | 2005-12-01 |
EP1750616A2 (en) | 2007-02-14 |
AU2005244993B2 (en) | 2011-03-31 |
JP2007537842A (en) | 2007-12-27 |
WO2005112821A3 (en) | 2006-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005244993B2 (en) | Enhanced biological fixation of grafts | |
EP2347731A1 (en) | Enhanced biological fixation of grafts | |
US11911270B2 (en) | Stent structures for use with valve replacements | |
CA2562463C (en) | Stent graft repair device | |
JP6690834B2 (en) | Artificial valve and method of manufacturing artificial valve | |
US7175652B2 (en) | Stent graft with improved proximal end | |
US7887576B2 (en) | Endoluminal device with extracellular matrix material and methods | |
EP2165675B1 (en) | Stent-graft fastening | |
JP4887159B2 (en) | Intracavity prosthetic device and method of forming the same | |
EP2073753B1 (en) | Synthetic blood vessel grafts | |
US6514283B2 (en) | Intraluminal lining | |
JP2022515360A (en) | Fabric material for medical devices | |
US20020052649A1 (en) | Graft having region for biological seal formation | |
KR20030017508A (en) | Endovascular stent graft | |
WO2004105636A2 (en) | Endovascular graft including substructure for positioning and sealing within vasculature | |
PL211860B1 (en) | Valve stent system | |
EP0783282B1 (en) | Cardiovascular graft | |
CN217091022U (en) | Artificial blood vessel with variable supporting force | |
CN114010367A (en) | Artificial blood vessel with variable supporting force |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2567296 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007527502 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005244993 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005757101 Country of ref document: EP |
|
ENP | Entry into the national phase in: |
Ref document number: 2005244993 Country of ref document: AU Date of ref document: 20050520 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005244993 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005757101 Country of ref document: EP |